J. Halperin

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)

C. Michael Gibson, Roxana Mehran, Christoph Bode et al. · American Heart Journal · 2014 · 171 citations

Medicine, Cardiology, Pharmacology +17

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

W Schuyler Jones, Anne S. Hellkamp, J. Halperin et al. · European Heart Journal · 2013 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes

Wobo Bekwelem, S. J. Connolly, J. Halperin · Journal of Vascular Surgery · 2016 · 16 citations · Full text

Medicine, Cardiology, Surgery +15

Sudden hemodynamic collapse following relief of cardiac tamponade in aortic dissection

Neil L. Coplan, Bruce Goldman, Giulia Mechanic et al. · American Heart Journal · 1986 · 11 citations

Medicine, Cardiology, Surgery +16

AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING)

Valentı́n Fuster, Lars Rydén, D.S. Cannom et al. · Rational Pharmacotherapy in Cardiology · 2007 · 11 citations · Full text

Medicine, Cardiology, Internal Medicine +17